Anti-myelin basic protein and anti-proteolipid protein specific forms of multiple sclerosis

Human myelin basic protein (hMBP) and proteolipid protein (PLP) were used as antigens in a solid‐phase radioimmunoassay to determine relative frequencies of anti‐MBP and anti‐PLP in cerebrospinal fluid (CSF) of optic neuritis and multiple sclerosis (MS) patients. Forty‐nine of 55 patients with optic...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Annals of neurology 1994-03, Vol.35 (3), p.280-289
Hauptverfasser: Warren, Kenneth G., Catz, Ingrid, Johnson, Edward, Mielke, Bruce
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 289
container_issue 3
container_start_page 280
container_title Annals of neurology
container_volume 35
creator Warren, Kenneth G.
Catz, Ingrid
Johnson, Edward
Mielke, Bruce
description Human myelin basic protein (hMBP) and proteolipid protein (PLP) were used as antigens in a solid‐phase radioimmunoassay to determine relative frequencies of anti‐MBP and anti‐PLP in cerebrospinal fluid (CSF) of optic neuritis and multiple sclerosis (MS) patients. Forty‐nine of 55 patients with optic neuritis had increased CSF anti‐MBP and the remaining 6 had increased anti‐PLP. Of 385 MS patients, MS relapse: 173 of 180 patients had increased anti‐MBP, 5 of the remaining 7 patients had elevated anti‐PLP, and 2 had neither of these autoantibodies. Progressive MS: 111 of 116 patients had increased anti‐MBP in either free and/or bound form, of the remaining 5 patients 4 had increased anti‐PLP, and 1 had neither anti‐MBP nor anti‐PLP. MS remission: 15 of 87 patients had somewhat increased anti‐MBP, none had anti‐PLP. IgG was purified by affinity chromatography from necropsy central nervous system (CNS) tissue samples of 4 individual patients with clinically definite and neuropathologically confirmed MS. Three of these 4 patients who had increased levels of CSF anti‐MBP also had increased anti‐MBP titers in CNS tissue‐extracted IgG. The fourth patient who had anti‐PLP in CSF also had anti‐PLP in brain tissue IgG. These autoantibodies were not detected simultaneously in any patient. These results suggest that there are at least two immunologically distinct forms of MS, i.e., a common form highly associated with anti‐MBP and more frequent prominent inflammatory characteristics in CSF and CNS, and an infrequent form associated with anti‐PLP in CSF and tissue, and less abundant inflammation. Anti‐MBP purified from CNS tissue IgG by antigen‐specific affinity chromatography was reacted with synthetic peptides of hMBP. The anti‐MBP epitope on the hMBP molecule was restricted between residues 75 and 106. The PLP epitope for anti‐PLP has not as yet been determined. These observations have theoretical implications for anticipated future specific immunotherapy of MS.
doi_str_mv 10.1002/ana.410350307
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_76383386</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>76383386</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3187-66948e940cdfcb4ef501e520cfb2d212486315e715dbbb3b825a34cf6b4331823</originalsourceid><addsrcrecordid>eNp9kM1rFTEUxYNY6vPpskthFuJu2iQ3HzPLR9W2WFoeVBS7CEkmgbSZDyfz0PffG_uGoasuQkjO7557OAidEHxKMKZnutOnjGDgGLB8hVaEAykryurXaIVBsJITYG_Q25QeMMa1IPgYHUueZ-tqhe433RTKdu9i6AqjU7DFMPaTyy_dNflk9emjj2EIzSKmwdngM-37sU1F74t2F6cwRFckG93Yp5DeoSOvY3Lv53uNvn_9cnd-WV7fXlydb65LC6SSpRA1q1zNsG28Ncx5jonjFFtvaEMJZZUAwp0kvDHGgKko18CsF4ZBNqCwRp8Ovjnc751Lk2pDsi5G3bl-l5QUUAFklzUqD6DN-dLovBrG0OpxrwhW_8tUuUy1lJn5D7PxzrSuWei5vax_nHWdrI5-1J0NacGglhWnJGPygP0J0e1f3qk2N5vnAebAIU3u7zKpx0clJEiuftxcqF-Xn7fb7TehfsI_h5GcZg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>76383386</pqid></control><display><type>article</type><title>Anti-myelin basic protein and anti-proteolipid protein specific forms of multiple sclerosis</title><source>MEDLINE</source><source>Access via Wiley Online Library</source><creator>Warren, Kenneth G. ; Catz, Ingrid ; Johnson, Edward ; Mielke, Bruce</creator><creatorcontrib>Warren, Kenneth G. ; Catz, Ingrid ; Johnson, Edward ; Mielke, Bruce</creatorcontrib><description>Human myelin basic protein (hMBP) and proteolipid protein (PLP) were used as antigens in a solid‐phase radioimmunoassay to determine relative frequencies of anti‐MBP and anti‐PLP in cerebrospinal fluid (CSF) of optic neuritis and multiple sclerosis (MS) patients. Forty‐nine of 55 patients with optic neuritis had increased CSF anti‐MBP and the remaining 6 had increased anti‐PLP. Of 385 MS patients, MS relapse: 173 of 180 patients had increased anti‐MBP, 5 of the remaining 7 patients had elevated anti‐PLP, and 2 had neither of these autoantibodies. Progressive MS: 111 of 116 patients had increased anti‐MBP in either free and/or bound form, of the remaining 5 patients 4 had increased anti‐PLP, and 1 had neither anti‐MBP nor anti‐PLP. MS remission: 15 of 87 patients had somewhat increased anti‐MBP, none had anti‐PLP. IgG was purified by affinity chromatography from necropsy central nervous system (CNS) tissue samples of 4 individual patients with clinically definite and neuropathologically confirmed MS. Three of these 4 patients who had increased levels of CSF anti‐MBP also had increased anti‐MBP titers in CNS tissue‐extracted IgG. The fourth patient who had anti‐PLP in CSF also had anti‐PLP in brain tissue IgG. These autoantibodies were not detected simultaneously in any patient. These results suggest that there are at least two immunologically distinct forms of MS, i.e., a common form highly associated with anti‐MBP and more frequent prominent inflammatory characteristics in CSF and CNS, and an infrequent form associated with anti‐PLP in CSF and tissue, and less abundant inflammation. Anti‐MBP purified from CNS tissue IgG by antigen‐specific affinity chromatography was reacted with synthetic peptides of hMBP. The anti‐MBP epitope on the hMBP molecule was restricted between residues 75 and 106. The PLP epitope for anti‐PLP has not as yet been determined. These observations have theoretical implications for anticipated future specific immunotherapy of MS.</description><identifier>ISSN: 0364-5134</identifier><identifier>EISSN: 1531-8249</identifier><identifier>DOI: 10.1002/ana.410350307</identifier><identifier>PMID: 7510098</identifier><identifier>CODEN: ANNED3</identifier><language>eng</language><publisher>Hoboken: Wiley Subscription Services, Inc., A Wiley Company</publisher><subject>Amino Acid Sequence ; Autoantibodies - cerebrospinal fluid ; Autoantibodies - isolation &amp; purification ; Biological and medical sciences ; Brain - pathology ; Central Nervous System - immunology ; Humans ; Magnetic Resonance Imaging ; Medical sciences ; Molecular Sequence Data ; Multiple Sclerosis - immunology ; Multiple Sclerosis - pathology ; Multiple sclerosis and variants. Guillain barré syndrome and other inflammatory polyneuropathies. Leukoencephalitis ; Myelin Basic Protein - immunology ; Myelin Proteins - immunology ; Myelin Proteolipid Protein ; Neurology ; Optic Neuritis - immunology ; Radioimmunoassay</subject><ispartof>Annals of neurology, 1994-03, Vol.35 (3), p.280-289</ispartof><rights>Copyright © 1994 American Neurological Association</rights><rights>1994 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3187-66948e940cdfcb4ef501e520cfb2d212486315e715dbbb3b825a34cf6b4331823</citedby><cites>FETCH-LOGICAL-c3187-66948e940cdfcb4ef501e520cfb2d212486315e715dbbb3b825a34cf6b4331823</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1002%2Fana.410350307$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1002%2Fana.410350307$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>315,781,785,1418,27928,27929,45578,45579</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=3978521$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/7510098$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Warren, Kenneth G.</creatorcontrib><creatorcontrib>Catz, Ingrid</creatorcontrib><creatorcontrib>Johnson, Edward</creatorcontrib><creatorcontrib>Mielke, Bruce</creatorcontrib><title>Anti-myelin basic protein and anti-proteolipid protein specific forms of multiple sclerosis</title><title>Annals of neurology</title><addtitle>Ann Neurol</addtitle><description>Human myelin basic protein (hMBP) and proteolipid protein (PLP) were used as antigens in a solid‐phase radioimmunoassay to determine relative frequencies of anti‐MBP and anti‐PLP in cerebrospinal fluid (CSF) of optic neuritis and multiple sclerosis (MS) patients. Forty‐nine of 55 patients with optic neuritis had increased CSF anti‐MBP and the remaining 6 had increased anti‐PLP. Of 385 MS patients, MS relapse: 173 of 180 patients had increased anti‐MBP, 5 of the remaining 7 patients had elevated anti‐PLP, and 2 had neither of these autoantibodies. Progressive MS: 111 of 116 patients had increased anti‐MBP in either free and/or bound form, of the remaining 5 patients 4 had increased anti‐PLP, and 1 had neither anti‐MBP nor anti‐PLP. MS remission: 15 of 87 patients had somewhat increased anti‐MBP, none had anti‐PLP. IgG was purified by affinity chromatography from necropsy central nervous system (CNS) tissue samples of 4 individual patients with clinically definite and neuropathologically confirmed MS. Three of these 4 patients who had increased levels of CSF anti‐MBP also had increased anti‐MBP titers in CNS tissue‐extracted IgG. The fourth patient who had anti‐PLP in CSF also had anti‐PLP in brain tissue IgG. These autoantibodies were not detected simultaneously in any patient. These results suggest that there are at least two immunologically distinct forms of MS, i.e., a common form highly associated with anti‐MBP and more frequent prominent inflammatory characteristics in CSF and CNS, and an infrequent form associated with anti‐PLP in CSF and tissue, and less abundant inflammation. Anti‐MBP purified from CNS tissue IgG by antigen‐specific affinity chromatography was reacted with synthetic peptides of hMBP. The anti‐MBP epitope on the hMBP molecule was restricted between residues 75 and 106. The PLP epitope for anti‐PLP has not as yet been determined. These observations have theoretical implications for anticipated future specific immunotherapy of MS.</description><subject>Amino Acid Sequence</subject><subject>Autoantibodies - cerebrospinal fluid</subject><subject>Autoantibodies - isolation &amp; purification</subject><subject>Biological and medical sciences</subject><subject>Brain - pathology</subject><subject>Central Nervous System - immunology</subject><subject>Humans</subject><subject>Magnetic Resonance Imaging</subject><subject>Medical sciences</subject><subject>Molecular Sequence Data</subject><subject>Multiple Sclerosis - immunology</subject><subject>Multiple Sclerosis - pathology</subject><subject>Multiple sclerosis and variants. Guillain barré syndrome and other inflammatory polyneuropathies. Leukoencephalitis</subject><subject>Myelin Basic Protein - immunology</subject><subject>Myelin Proteins - immunology</subject><subject>Myelin Proteolipid Protein</subject><subject>Neurology</subject><subject>Optic Neuritis - immunology</subject><subject>Radioimmunoassay</subject><issn>0364-5134</issn><issn>1531-8249</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1994</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kM1rFTEUxYNY6vPpskthFuJu2iQ3HzPLR9W2WFoeVBS7CEkmgbSZDyfz0PffG_uGoasuQkjO7557OAidEHxKMKZnutOnjGDgGLB8hVaEAykryurXaIVBsJITYG_Q25QeMMa1IPgYHUueZ-tqhe433RTKdu9i6AqjU7DFMPaTyy_dNflk9emjj2EIzSKmwdngM-37sU1F74t2F6cwRFckG93Yp5DeoSOvY3Lv53uNvn_9cnd-WV7fXlydb65LC6SSpRA1q1zNsG28Ncx5jonjFFtvaEMJZZUAwp0kvDHGgKko18CsF4ZBNqCwRp8Ovjnc751Lk2pDsi5G3bl-l5QUUAFklzUqD6DN-dLovBrG0OpxrwhW_8tUuUy1lJn5D7PxzrSuWei5vax_nHWdrI5-1J0NacGglhWnJGPygP0J0e1f3qk2N5vnAebAIU3u7zKpx0clJEiuftxcqF-Xn7fb7TehfsI_h5GcZg</recordid><startdate>199403</startdate><enddate>199403</enddate><creator>Warren, Kenneth G.</creator><creator>Catz, Ingrid</creator><creator>Johnson, Edward</creator><creator>Mielke, Bruce</creator><general>Wiley Subscription Services, Inc., A Wiley Company</general><general>Willey-Liss</general><scope>BSCLL</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>199403</creationdate><title>Anti-myelin basic protein and anti-proteolipid protein specific forms of multiple sclerosis</title><author>Warren, Kenneth G. ; Catz, Ingrid ; Johnson, Edward ; Mielke, Bruce</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3187-66948e940cdfcb4ef501e520cfb2d212486315e715dbbb3b825a34cf6b4331823</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1994</creationdate><topic>Amino Acid Sequence</topic><topic>Autoantibodies - cerebrospinal fluid</topic><topic>Autoantibodies - isolation &amp; purification</topic><topic>Biological and medical sciences</topic><topic>Brain - pathology</topic><topic>Central Nervous System - immunology</topic><topic>Humans</topic><topic>Magnetic Resonance Imaging</topic><topic>Medical sciences</topic><topic>Molecular Sequence Data</topic><topic>Multiple Sclerosis - immunology</topic><topic>Multiple Sclerosis - pathology</topic><topic>Multiple sclerosis and variants. Guillain barré syndrome and other inflammatory polyneuropathies. Leukoencephalitis</topic><topic>Myelin Basic Protein - immunology</topic><topic>Myelin Proteins - immunology</topic><topic>Myelin Proteolipid Protein</topic><topic>Neurology</topic><topic>Optic Neuritis - immunology</topic><topic>Radioimmunoassay</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Warren, Kenneth G.</creatorcontrib><creatorcontrib>Catz, Ingrid</creatorcontrib><creatorcontrib>Johnson, Edward</creatorcontrib><creatorcontrib>Mielke, Bruce</creatorcontrib><collection>Istex</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Annals of neurology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Warren, Kenneth G.</au><au>Catz, Ingrid</au><au>Johnson, Edward</au><au>Mielke, Bruce</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Anti-myelin basic protein and anti-proteolipid protein specific forms of multiple sclerosis</atitle><jtitle>Annals of neurology</jtitle><addtitle>Ann Neurol</addtitle><date>1994-03</date><risdate>1994</risdate><volume>35</volume><issue>3</issue><spage>280</spage><epage>289</epage><pages>280-289</pages><issn>0364-5134</issn><eissn>1531-8249</eissn><coden>ANNED3</coden><abstract>Human myelin basic protein (hMBP) and proteolipid protein (PLP) were used as antigens in a solid‐phase radioimmunoassay to determine relative frequencies of anti‐MBP and anti‐PLP in cerebrospinal fluid (CSF) of optic neuritis and multiple sclerosis (MS) patients. Forty‐nine of 55 patients with optic neuritis had increased CSF anti‐MBP and the remaining 6 had increased anti‐PLP. Of 385 MS patients, MS relapse: 173 of 180 patients had increased anti‐MBP, 5 of the remaining 7 patients had elevated anti‐PLP, and 2 had neither of these autoantibodies. Progressive MS: 111 of 116 patients had increased anti‐MBP in either free and/or bound form, of the remaining 5 patients 4 had increased anti‐PLP, and 1 had neither anti‐MBP nor anti‐PLP. MS remission: 15 of 87 patients had somewhat increased anti‐MBP, none had anti‐PLP. IgG was purified by affinity chromatography from necropsy central nervous system (CNS) tissue samples of 4 individual patients with clinically definite and neuropathologically confirmed MS. Three of these 4 patients who had increased levels of CSF anti‐MBP also had increased anti‐MBP titers in CNS tissue‐extracted IgG. The fourth patient who had anti‐PLP in CSF also had anti‐PLP in brain tissue IgG. These autoantibodies were not detected simultaneously in any patient. These results suggest that there are at least two immunologically distinct forms of MS, i.e., a common form highly associated with anti‐MBP and more frequent prominent inflammatory characteristics in CSF and CNS, and an infrequent form associated with anti‐PLP in CSF and tissue, and less abundant inflammation. Anti‐MBP purified from CNS tissue IgG by antigen‐specific affinity chromatography was reacted with synthetic peptides of hMBP. The anti‐MBP epitope on the hMBP molecule was restricted between residues 75 and 106. The PLP epitope for anti‐PLP has not as yet been determined. These observations have theoretical implications for anticipated future specific immunotherapy of MS.</abstract><cop>Hoboken</cop><pub>Wiley Subscription Services, Inc., A Wiley Company</pub><pmid>7510098</pmid><doi>10.1002/ana.410350307</doi><tpages>10</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0364-5134
ispartof Annals of neurology, 1994-03, Vol.35 (3), p.280-289
issn 0364-5134
1531-8249
language eng
recordid cdi_proquest_miscellaneous_76383386
source MEDLINE; Access via Wiley Online Library
subjects Amino Acid Sequence
Autoantibodies - cerebrospinal fluid
Autoantibodies - isolation & purification
Biological and medical sciences
Brain - pathology
Central Nervous System - immunology
Humans
Magnetic Resonance Imaging
Medical sciences
Molecular Sequence Data
Multiple Sclerosis - immunology
Multiple Sclerosis - pathology
Multiple sclerosis and variants. Guillain barré syndrome and other inflammatory polyneuropathies. Leukoencephalitis
Myelin Basic Protein - immunology
Myelin Proteins - immunology
Myelin Proteolipid Protein
Neurology
Optic Neuritis - immunology
Radioimmunoassay
title Anti-myelin basic protein and anti-proteolipid protein specific forms of multiple sclerosis
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-17T08%3A48%3A52IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Anti-myelin%20basic%20protein%20and%20anti-proteolipid%20protein%20specific%20forms%20of%20multiple%20sclerosis&rft.jtitle=Annals%20of%20neurology&rft.au=Warren,%20Kenneth%20G.&rft.date=1994-03&rft.volume=35&rft.issue=3&rft.spage=280&rft.epage=289&rft.pages=280-289&rft.issn=0364-5134&rft.eissn=1531-8249&rft.coden=ANNED3&rft_id=info:doi/10.1002/ana.410350307&rft_dat=%3Cproquest_cross%3E76383386%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=76383386&rft_id=info:pmid/7510098&rfr_iscdi=true